Biopsomic Company Profile: Funding, Investors & Partnerships

Biopsomic

Biopsomic is developing a new liquid biopsy for cancer prognosis.From a simple blood draw, our non-invasive test probes the actual disease state and evaluates the risk of developing metastatic disease based on the analysis of nanovesicles called exosomes.These new insights allow oncologists to make proper well-informed clinical decisions and ensure optimal outcomes for patients.We are currently looking for new team members.Biopsomic is developing a new liquid biopsy for cancer prognosis.From a simple blood draw, our non-i Show More

Alpha Score

46.5